tag paul-janssen 
pharmaphorum
FEBRUARY 26, 2021
The joining of Janssen. It was in 1961 that Belgium’s Janssen Pharmaceutica N.V. Its founder, Dr Paul Janssen, is recognised as one of the most innovative and prolific pharmaceutical researchers of the 20th century. Acquisitions post-Janssen. joined the J&J Family of Companies. COVID and beyond.
Drug Discovery World
NOVEMBER 9, 2023
Ulrike Philippar, PhD, Senior Director & Head, Oncology & Discovery Hematological Malignancies, Janssen Pharmaceutica, on: ‘T cell redirecting antibodies for the treatment of hematological malignancies’. Fabian Richter, PhD, Immatics Biotechnologies, on: ‘TCER development: safety aspects from discovery to lead candidate’.
Expert insights. Personalized for you.
126 
Let's personalize your content